AbbVie Inc. vs Peak Processing Limited
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
Market cap history
● AbbVie Inc.● Peak Processing Limited
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #27 in the world | Peak Processing Limited PKP.AX |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇦🇺 Australia |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 2013 | — |
| Size | ||
| Market cap | $514.0 B | — |
| Revenue | $61.2 B | — |
| Net income | $4.2 B | — |
| Employees | 57,000 | — |
| Valuation | ||
| P/E ratio | 49.7× | — |
| Price to sales | 7.8× | — |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2% | — |
| Operating margin | 24.6% | — |
| Net margin | 6.9% | — |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6% | — |
| Revenue growth, 3 years a year | 1.8% | — |
| Earnings per share growth | -1.3% | — |
| Financial strength | ||
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap — |